HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enilton A Camargo Selected Research

piratoxin I

12/2005Characterization of the acute pancreatitis induced by secretory phospholipases A2 in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Enilton A Camargo Research Topics

Disease

10Inflammation (Inflammations)
01/2022 - 07/2008
5Edema (Dropsy)
12/2018 - 09/2010
5Pancreatitis
07/2012 - 12/2005
4Pain (Aches)
01/2022 - 10/2011
4Hyperalgesia
06/2019 - 10/2011
2Lung Injury
01/2020 - 12/2005
2Necrosis
12/2018 - 12/2005
2Body Weight (Weight, Body)
12/2015 - 07/2013
2Peritonitis
12/2012 - 09/2010
2Cardiovascular Diseases (Cardiovascular Disease)
04/2010 - 07/2007
2Pneumonia (Pneumonitis)
11/2006 - 11/2005
1Stomach Ulcer (Gastric Ulcer)
02/2022
1Facial Pain (Myofacial Pain)
01/2022
1Otitis
02/2021
1Pulmonary Emphysema
01/2020
1Ulcerative Colitis
05/2017
1Wounds and Injuries (Trauma)
10/2016
1Weight Gain
02/2016
1Insulin Resistance
02/2016
1Overweight
12/2015
1Fibromyalgia (Fibrositis)
10/2014
1Myalgia
10/2014
1Obesity
07/2013
1Cystitis
01/2013
1Hemorrhagic Cystitis
01/2013
1Pleurisy (Pleuritis)
03/2012
1Erectile Dysfunction
04/2010
1Hypersensitivity (Allergy)
02/2009
1Staphylococcal Infections
11/2006

Drug/Important Bio-Agent (IBA)

5CarrageenanIBA
01/2022 - 09/2010
5Peroxidase (Myeloperoxidase)IBA
12/2018 - 12/2005
4carvacrolIBA
01/2020 - 03/2012
3Ethanol (Ethyl Alcohol)IBA
02/2022 - 07/2012
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2013 - 05/2008
3NitritesIBA
07/2012 - 05/2008
3AmylasesFDA Link
07/2012 - 12/2005
3Secretory Phospholipases A2IBA
10/2011 - 12/2005
3VenomsIBA
10/2011 - 12/2005
2Monoterpenes (Monoterpenoids)IBA
01/2022 - 10/2016
2Malondialdehyde (Propanedial)IBA
01/2020 - 07/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2019 - 11/2006
2CyclodextrinsIBA
12/2018 - 10/2014
2Insulin (Novolin)FDA Link
02/2016 - 07/2013
2Proteins (Proteins, Gene)FDA Link
10/2014 - 04/2010
2NitratesIBA
07/2012 - 05/2008
2Prostaglandins EIBA
03/2012 - 11/2006
1myrtenolIBA
01/2022
1CytokinesIBA
01/2022
1Polysorbates (PSML)FDA Link
01/2022
1AntioxidantsIBA
02/2021
1SmokeIBA
01/2020
1Lipid NanoparticlesIBA
01/2020
1Creatine Kinase (Creatine Phosphokinase)IBA
06/2019
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
12/2018
1InterleukinsIBA
12/2018
1Interleukin-6 (Interleukin 6)IBA
12/2018
1Interleukin-10 (Interleukin 10)IBA
12/2018
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2017
1Immunologic Factors (Immunomodulators)IBA
05/2017
1ChitosanIBA
10/2016
1isoborneol (borneol)IBA
10/2016
1Blood Glucose (Blood Sugar)IBA
02/2016
1Drinking WaterIBA
02/2016
1LipidsIBA
12/2015
1Analgesics (Analgesic Drugs)IBA
10/2014
1linaloolIBA
10/2014
1Glucose (Dextrose)FDA LinkGeneric
07/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2013
1Mesna (Coenzyme M)FDA LinkGeneric
01/2013
1Formaldehyde (Formol)FDA Link
12/2012
1Freund's AdjuvantIBA
12/2012
1Lipase (Acid Lipase)FDA Link
07/2012
1LipopolysaccharidesIBA
03/2012
1Dopamine (Intropin)FDA LinkGeneric
03/2012
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
10/2011
1SR 140333IBA
10/2011
1TachykininsIBA
10/2011
1Phospholipases (Phospholipase)IBA
10/2011
1NADP (NADPH)IBA
04/2010
1NADPH Oxidases (NAD(P)H oxidase)IBA
04/2010
14- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
04/2010
1Nitric Oxide Synthase (NO Synthase)IBA
02/2009
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
02/2009
1Substance PIBA
07/2008
1BradykininIBA
07/2008
1Endothelium-Dependent Relaxing Factors (Endothelium Derived Relaxing Factor)IBA
07/2007
1Enterotoxins (Enterotoxin)IBA
11/2006
1bothropstoxin IIIBA
12/2005
1piratoxin IIBA
12/2005
1Staphylococcal enterotoxin AIBA
11/2005

Therapy/Procedure

3Therapeutics
06/2019 - 01/2013